244 related articles for article (PubMed ID: 26933804)
1. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway.
Li L; Liang S; Wasylishen AR; Zhang Y; Yang X; Zhou B; Shan L; Han X; Mu T; Wang G; Xiong S
Oncotarget; 2016 Apr; 7(14):18021-35. PubMed ID: 26933804
[TBL] [Abstract][Full Text] [Related]
2. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
[TBL] [Abstract][Full Text] [Related]
3. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
Xiong S; Tu H; Kollareddy M; Pant V; Li Q; Zhang Y; Jackson JG; Suh YA; Elizondo-Fraire AC; Yang P; Chau G; Tashakori M; Wasylishen AR; Ju Z; Solomon H; Rotter V; Liu B; El-Naggar AK; Donehower LA; Martinez LA; Lozano G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11145-50. PubMed ID: 25024203
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
5. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
6. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Xia W; Bai H; Deng Y; Yang Y
J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
[TBL] [Abstract][Full Text] [Related]
7. ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.
Zhang Y; Hu Q; Li G; Li L; Liang S; Zhang Y; Liu J; Fan Z; Li L; Zhou B; Ruan Y; Yang X; Chen S; Mu T; Wang G; Xiong S
Cell Physiol Biochem; 2018; 48(3):1099-1111. PubMed ID: 30041188
[TBL] [Abstract][Full Text] [Related]
8. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway.
Tingting R; Wei G; Changliang P; Xinchang L; Yi Y
Cancer Biol Ther; 2010 Aug; 10(3):251-7. PubMed ID: 20592496
[TBL] [Abstract][Full Text] [Related]
11. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
12. Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation.
Jie Z; Xie Z; Zhao X; Sun X; Yu H; Pan X; Shen S; Qin A; Fang X; Fan S
J Cell Physiol; 2019 Apr; 234(4):4167-4178. PubMed ID: 30146723
[TBL] [Abstract][Full Text] [Related]
13. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
14. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
15. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
16. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
17. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
18. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
[TBL] [Abstract][Full Text] [Related]
19. Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway.
Zhang L; Yang C; Huang Y; Huang H; Yuan X; Zhang P; Ye C; Wei M; Wang Y; Luo X; Luo J
Biomed Pharmacother; 2021 Feb; 134():111155. PubMed ID: 33370628
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
Silva G; Aboussekhra A
Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
